Obinutuzumab Alone or Combined with Chemotherapy in Previously Untreated (Fit or Unfit) or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients: Final Results from the Phase IIIb GREEN Safety Study with a Focus on Efficacy

Stilgenbauer S., Bosch F., Leblond V., İLHAN O., Kisro J., Mahe B., ...More

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 7 - 10 December 2019, vol.134, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 134
• Doi Number: 10.1182/blood-2019-123419
• City: Florida
• Country: United States Of America
• Ankara University Affiliated: Yes